Trade

with

Mylan Inc
(NASDAQ: MYL)
US Markets Closed
AdChoices
50.36
-1.69
-3.24%
After Hours :
50.36
0.00
0.00%

Open

52.00

Previous Close

52.05

Volume (Avg)

6.96M (4.92M)

Day's Range

50.33-52.18

52Wk Range

36.97-57.52

Market Cap.

19.47B

Dividend Rate ( Yield )

-

Beta

1.19

Shares Outstanding

374.05M

P/E Ratio (EPS)

35.59 (1.46)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 6.91B

    • Net Income

    • 623.71M

    • Market Cap.

    • 19.47B

    • Enterprise Value

    • 27.50B

    • Net Profit Margin %

    • 8.14

    • PEG (Price/Earnings Growth) Ratio

    • 0.99

    • Beta

    • 1.19

    • Forward P/E

    • 12.79

    • Price/Sales

    • 2.89

    • Price/Book Value

    • 5.84

    • Price/Cash flow

    • 16.13

      • EBITDA

      • 1.58B

      • Return on Capital %

      • 4.17

      • Return on Equity %

      • 18.53

      • Return on Assets %

      • 4.17

      • Book Value/Share

      • 8.91

      • Shares Outstanding

      • 374.05M

      • Last Split Factor (Date)

      • 3:2 (10/9/2003)

      • Last Dividend (Ex-Date)

      • 0.06 (6/27/2007)

      • Dividend Declaration Date

      • 6/18/2007

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 63.25

        • Credit Rating

        • BBB-

        • Analysts

        • 6

        • EPS Estimate

        • 3.55

        • Cashflow Estimate

        • 4.31

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 8.00

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -2.70

          • -26.33

          • Net Income

            Q/Q (last year)

          • -29.50

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 6.10

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 44.20

            • 64.72

            • Pre-Tax Margin

            • 9.51

            • 13.77

            • Net Profit Margin

            • 8.14

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 42.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 8.90

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 6.60

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 2.37

              • 0.33

              • Current Ratio

              • 1.72

              • 1.52

              • Quick Ratio

              • 0.75

              • 0.87

              • Interest Coverage

              • 3.11

              • 6.77

              • Leverage Ratio

              • 4.68

              • 1.91

              • Book Value/Share

              • 8.91

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 35.59

                • 63.69

                • P/E Ratio 5-Year High

                • 39.30

                • 237.47

                • P/E Ratio 5-Year Low

                • 10.58

                • 19.71

                • Price/Sales Ratio

                • 2.89

                • 3.57

                • Price/Book Value

                • 5.84

                • 3.35

                • Price/Cash Flow Ratio

                • 16.13

                • 21.41

                • Key Metrics

                • Company

                  • Shares Short

                    as of 9/30/2014

                  • 29.37M

                  • Short Ratio

                    as of 9/30/2014

                  • 7.31

                  • Short % of Float

                    as of 9/30/2014

                  • 8.00

                  • Shares Short

                    prior month

                  • 28.98M

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 0.00

                    • Dividend Date

                    • 6/18/2007

                    • Ex-Dividend Date

                    • 6/27/2007

                    • Last Split Factor

                      new per old

                    • 3:2

                    • Last Split Date

                    • 10/9/2003

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 18.53

                        (12.70)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • 4.17

                        (3.50)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • 8.27

                        (7.60)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • 29.01k

                      • 27.79k

                      • Inventory Turnover

                      • 2.32

                      • 1.80

                      • Asset Turnover

                      • 0.51

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      1.14B
                      Operating Margin
                      16.44
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      16.13
                      Ownership

                      Institutional Ownership

                      91.05%

                      Top 10 Institutions

                      30.20%

                      Mutual Fund Ownership

                      39.37%

                      Float

                      98.76%

                      5% / Insider Ownership

                      0.85%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Mid-Cap Index Fund

                      •  

                        6,399,046

                      • 1.18

                      • 1.71

                      • Vanguard Total Stock Mkt Idx

                      •  

                        6,094,591

                      • 0.60

                      • 1.63

                      • iShares Nasdaq Biotechnology

                      •  

                        4,961,138

                      • -0.69

                      • 1.47

                      • Vanguard Health Care Fund

                      •  

                        4,775,700

                      • 0.00

                      • 1.28

                      • Vanguard Five Hundred Index Fund

                      •  

                        3,883,280

                      • 0.32

                      • 1.04

                      • Vanguard Institutional Index Fund

                      •  

                        3,789,152

                      • -0.99

                      • 1.01

                      • SPDR® S&P 500 ETF

                      •  

                        3,615,467

                      • -2.13

                      • 1.07

                      • PowerShares QQQ

                      •  

                        3,060,244

                      • -1.08

                      • 0.94

                      • Goldman Sachs Growth Opportunities Fund

                      •  

                        2,386,184

                      • -0.57

                      • 0.64

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        27,692,860

                      • +2.27%

                      • 7.41

                      • State Street Corp

                      •  

                        15,661,083

                      • -0.38%

                      • 4.19

                      • Paulson & Company Inc

                      •  

                        12,130,700

                      • 0.00%

                      • 3.24

                      • Goldman Sachs Asset Management, L.P.

                      •  

                        11,704,126

                      • +90.43%

                      • 3.13

                      • BlackRock Fund Advisors

                      •  

                        11,131,342

                      • +0.51%

                      • 2.98

                      • Wellington Management Company, LLP

                      •  

                        10,440,382

                      • -19.19%

                      • 2.79

                      • Discovery Capital Management LLC

                      •  

                        7,376,404

                      • +11.91%

                      • 1.97

                      • BMO Asset Management Inc.

                      •  

                        6,110,910

                      • +3.02%

                      • 1.63

                      • Government Pension Fund of Norway - Global

                      •  

                        5,482,627

                      • -23.42%

                      • 1.28

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Aggressive Growth

                      Style

                      Large Growth

                      Mylan Inc was incorporated in Pennsylvania in 1970. The Company together with its subsidiaries, is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharm...moreaceuticals. The Company offers 1,300 marketed products, to customers in 140 countries and territories. It also operates a research and development network that delivers a robust product pipeline. Additionally, the Company has a specialty business that is engaged in the respiratory and allergy therapies. It offers a range of dosage forms and delivery systems, including oral solids, topicals, liquids and semi-solids while engaging on those products that are difficult to formulate and manufacture, and typically have longer life cycles than traditional generic pharmaceutical...mores, including transdermal patches, high potency formulations, injectables, controlled-release and respiratory products. In addition, it offers antiretroviral therapies upon which HIV/AIDS patients in developing countries depend. The Company operates in two segments, Generics and Specialty. The generic pharmaceutical business is conducted primarily in the U.S. and Canada, Europe, the Middle East, and Africa and India, Australia, Japan, New Zealand and Brazil. The Generics segment develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages in the development, manufacture and sale of branded specialty nebulized and injectable products. The Company owns or licenses a number of patents in the U.S. and other countries covering certain products and have also developed brand names and trademarks for other products. In North America, the Company markets products directly to wholesalers, distributors, retail pharmacy chains, long-term care facilities, mail order pharmacies and GPOs. It also market its generic products indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, pharmacy benefit management companies and government entities. The Company’s competitors include other generic companies and branded drug companies that continue to sell or license branded pharmaceutical products after patent expirations and other statutory expirations. In the branded space, key competitors are generally other branded drug companies that compete based on its clinical characteristics and benefits.lessless

                      Key People

                      Heather Bresch

                      CEO/Director

                      Robert J. Coury

                      Chairman of the Board/Director

                      Rodney L. Piatt

                      Director/Vice Chairman of the Board

                      John D. Sheehan

                      CFO/Executive VP

                      C. B. Todd

                      Director Emeritus

                      • Mylan Inc

                      • 1000 Mylan Boulevard

                      • Canonsburg, PA 15317

                      • USA.Map

                      • Phone: +1 724 514-1800

                      • Fax: -

                      • mylan.com

                      Incorporated

                      1970

                      Employees

                      20,000

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: